Overview

  • Product name
    Naftopidil hydrochloride
  • Description
    α1 Adrenoceptor antagonist
  • Biological description
    α1 Adrenoceptor antagonist. pKi values are 3.7, 20 and 1.2 for α1a, α1b and α1d, respectively. Orally active. Implicated in benign prostate hyperplasia and bladder obstruction. Antihypertensive.
  • Purity
    > 98%

Properties

References

This product has been referenced in:
  • Kanda H  et al. Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest. Int J Cancer 122:444-51 (2008). Read more (PubMed: 17918159) »
  • Takei R  et al. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 79:447-54 (1999). Read more (PubMed: 10361884) »
  • Yamada S  et al. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy. Life Sci 50:127-35 (1992). Read more (PubMed: 1370569) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120756.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up